About: Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.32 (+6.42%)
LABTNASDAQLakewood-Amedex Biotherapeutics Inc. Common Stock
Lakewood-Amedex Biotherapeutics Inc. Common Stock share price
LABT price activity
Last Price
$2.320
Change (24hr)
0.14 USD (6.42%)
Volume
5.04M
Volume (4w avg)
-
Open
$2.20
Day Range
$2.13 - $2.61
Previous Close
$2.18
Last Trade
09 Sep, 8:26 pm GMT+0
Delayed
09 Sep, 8:26 pm GMT+0
LABT price performance
Delayed
09 Sep, 8:26 pm GMT+0
LABT Market Signals